This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Kos Pharmaceuticals Inc.Kos Reports Summary Results from Clinical Study on Benefits of Combining Aspirin with Optimized Niaspan(R) CF. Media Release: 25 Jul 2006. Available from: URL: http://www.businesswire.com
About this article
Cite this article
Combining optimised Niaspan CF [extended-release nicotinic acid caplet formulation] with aspirin appears to be beneficial. React. Wkly. 1113, 3 (2006). https://doi.org/10.2165/00128415-200611130-00009
- Public Health
- Nicotinic Acid
- Provocation Study